Pfizer
PFE
1,606 hedge funds and large institutions have $133B invested in Pfizer in 2013 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 616 increasing their positions, 724 reducing their positions, and 77 closing their positions.
5% more call options, than puts
Call options by funds: $1.22B | Put options by funds: $1.16B
0.06% more ownership
Funds ownership: 73.6% → 73.66% (+0.06%)
4% less capital invested
Capital invested by funds: $139B → $133B (-$5.46B)
6% less first-time investments, than exits
New positions opened: 72 | Existing positions closed: 77
1% less funds holding
Funds holding: 1,627 → 1,606 (-21)
12% less funds holding in top 10
Funds holding in top 10: 290 → 254 (-36)
15% less repeat investments, than reductions
Existing positions increased: 616 | Existing positions reduced: 724
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$294M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$224M |
| 3 |
SG Americas Securities
New York
|
+$146M |
| 4 |
Canada Life
Winnipeg,
Manitoba, Canada
|
+$125M |
| 5 |
Two Sigma Investments
New York
|
+$124M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$887M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$800M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$783M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$756M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$499M |
PFE Hedge Fund Activity: Q3 2013 in Review
1,606 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q3 2013, worth a combined $133B — down 3.9% from $139B a quarter earlier.
Sellers outnumbered buyers: 77 funds closed out of PFE and 72 opened new positions — a net loss of 5 holders — while 724 trimmed existing stakes and 616 added.
The largest buyer was Capital World Investors, adding an estimated $294M. The largest seller was Susquehanna International Group, cutting an estimated $887M.
- 1,606 institutional investors held Pfizer (PFE) as of Q3 2013, down from 1,627 in Q2 2013.
- Funds reported $133B of Pfizer stock for Q3 2013, down 3.9% quarter-over-quarter.
- 72 funds opened new Pfizer positions in Q3 2013 and 77 closed out, a net change of -5 holders.
- The largest Pfizer buyer in Q3 2013 was Capital World Investors, an estimated $294M added.
- The largest Pfizer seller in Q3 2013 was Susquehanna International Group, an estimated $887M sold.
Based on aggregated 13F filings for Q3 2013.